SCHEMBL30206568

SCHEMBL30206568

CNc1cnc(C(N)=O)c(Nc2ccc(N3CCOCC3)cc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EML4 Q9HC35 4/20 0.53
▸ ALK Q9UM73 4/20 0.53
▸ LCK P06239 1/20 0.52
▸ JAK3 P52333 1/20 0.52
▸ SYK P43405 7/20 0.51
▸ AURKA O14965 1/20 0.50
▸ CDK4 P11802 1/20 0.50
▸ CCNA2 P20248 1/20 0.50
▸ CDK2 P24941 1/20 0.50
▸ CCND3 P30281 1/20 0.50
▸ CDK6 Q00534 1/20 0.50
▸ MAPK9 P45984 2/20 0.48
▸ MAPK10 P53779 2/20 0.48
▸ MAPK8 P45983 1/20 0.48
▸ STAT6 P42226 3/20 0.48
▸ MAPKAPK5 Q8IW41 2/20 0.48
▸ RET P07949 1/20 0.48
▸ ROS1 P08922 1/20 0.48
▸ FLT3 P36888 1/20 0.48
▸ JAK2 O60674 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30802776 0.84 EML4 (0.55) EML4ALKLCKJAK3SYK
SCHEMBL18884550 0.82 JAK3 (0.62) EML4ALKLCKJAK3SYK
SCHEMBL30802783 0.81 SYK (0.52) EML4ALKLCKJAK3SYK
SCHEMBL29173494 0.80 EML4 (0.58) EML4ALKJAK3SYKAURKA
SCHEMBL30206068 0.80 EML4 (0.58) EML4ALKJAK3SYKAURKA
SCHEMBL30206185 0.80 JAK2 (0.54) EML4ALKSYKAURKACDK4
SCHEMBL29173352 0.78 SYK (0.53) EML4ALKSYKAURKACDK4
SCHEMBL30205943 0.78 SYK (0.53) EML4ALKSYKAURKACDK4
SCHEMBL13405489 0.77 PIM1 (0.64) EML4ALKSYKAURKACDK4
SCHEMBL30206344 0.77 EML4 (0.56) EML4ALKLCKJAK3SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
EP-4373817-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER Astrazeneca AB (SE) 2024-05-29 — — EP disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback